• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性心脏病:细胞因子的作用。

Inflammatory heart disease: a role for cytokines.

作者信息

Fairweather D, Rose N R

机构信息

Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD, USA.

出版信息

Lupus. 2005;14(9):646-51. doi: 10.1191/0961203305lu2192oa.

DOI:10.1191/0961203305lu2192oa
PMID:16218459
Abstract

Inflammatory heart disease is a rising concern worldwide. Similar mechanisms link autoimmune diseases, including the association of increased disease with proinflammatory cytokines and the importance of regulatory mechanisms in the control of chronic inflammation. Many pathogens including bacteria, protozoa and viruses have been associated with heart disease in patients, and are able to induce similar disease in animal models. Recognition of pathogens by the innate immune system leads to release of proinflammatory cytokines that both reduce infection and increase chronic inflammatory heart disease. Elevated levels of proinflammatory cytokines are able to overcome tolerance to chronic disease, indicating that environmental factors are important in determining progression to chronic heart disease. Understanding the mechanisms leading to chronic heart disease will be critical for developing effective therapies to reduce cardiac dysfunction and heart failure.

摘要

炎症性心脏病在全球范围内日益受到关注。自身免疫性疾病存在相似的机制,包括疾病增加与促炎细胞因子的关联以及调节机制在控制慢性炎症中的重要性。许多病原体,包括细菌、原生动物和病毒,都与患者的心脏病有关,并且能够在动物模型中诱发类似疾病。先天免疫系统对病原体的识别会导致促炎细胞因子的释放,这些因子既能减少感染,又会增加慢性炎症性心脏病。促炎细胞因子水平的升高能够克服对慢性病的耐受性,这表明环境因素在决定向慢性心脏病发展的过程中很重要。了解导致慢性心脏病的机制对于开发有效的治疗方法以减少心脏功能障碍和心力衰竭至关重要。

相似文献

1
Inflammatory heart disease: a role for cytokines.炎症性心脏病:细胞因子的作用。
Lupus. 2005;14(9):646-51. doi: 10.1191/0961203305lu2192oa.
2
Regulating inflammation in the heart.调节心脏炎症。
Int J Biomed Sci. 2007 Mar;3(1):9-13.
3
Role of innate and adaptive immune mechanisms in cardiac injury and repair.先天性和适应性免疫机制在心脏损伤与修复中的作用。
Nat Rev Immunol. 2015 Feb;15(2):117-29. doi: 10.1038/nri3800.
4
Immune activation in chronic heart failure.慢性心力衰竭中的免疫激活
Am J Cardiol. 2005 Jun 6;95(11A):3C-8C; discussion 38C-40C. doi: 10.1016/j.amjcard.2005.03.006.
5
Autoimmune myocarditis: cellular mediators of cardiac dysfunction.自身免疫性心肌炎:心脏功能障碍的细胞介质
Autoimmun Rev. 2004 Nov;3(7-8):476-86. doi: 10.1016/j.autrev.2004.08.009.
6
Natural killer cells in inflammatory heart disease.炎症性心脏病中的自然杀伤细胞。
Clin Immunol. 2017 Feb;175:26-33. doi: 10.1016/j.clim.2016.11.010. Epub 2016 Nov 25.
7
Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases.共生菌(正常微生物群)、黏膜免疫与慢性炎症及自身免疫性疾病。
Immunol Lett. 2004 May 15;93(2-3):97-108. doi: 10.1016/j.imlet.2004.02.005.
8
From infection to autoimmunity.从感染到自身免疫。
J Autoimmun. 2001 May;16(3):175-86. doi: 10.1006/jaut.2000.0492.
9
Viruses as adjuvants for autoimmunity: evidence from Coxsackievirus-induced myocarditis.病毒作为自身免疫的佐剂:来自柯萨奇病毒诱导的心肌炎的证据。
Rev Med Virol. 2005 Jan-Feb;15(1):17-27. doi: 10.1002/rmv.445.
10
Autoimmune myocarditis: past, present and future.自身免疫性心肌炎:过去、现在和未来。
J Autoimmun. 2009 Nov-Dec;33(3-4):282-9. doi: 10.1016/j.jaut.2009.07.009. Epub 2009 Aug 12.

引用本文的文献

1
Long-term cardiovascular outcomes after exercise-based cardiac rehabilitation among coronavirus disease 2019 survivors: A nationwide cohort study.2019冠状病毒病幸存者运动心脏康复后的长期心血管结局:一项全国性队列研究。
Tzu Chi Med J. 2025 Jun 5;37(3):293-298. doi: 10.4103/tcmj.tcmj_154_24. eCollection 2025 Jul-Sep.
2
Danshensu Ethyl Ester Alleviates LPS-Induced Acute Lung Injury by Targeting the NLRP3 Inflammasome.丹参素乙酯通过靶向NLRP3炎性小体减轻脂多糖诱导的急性肺损伤。
J Inflamm Res. 2025 Jul 4;18:8767-8785. doi: 10.2147/JIR.S517701. eCollection 2025.
3
Trends in mortality due to ischemic heart diseases among patients with Alzheimer's disease in the United States from 1999 to 2020.
1999年至2020年美国阿尔茨海默病患者缺血性心脏病死亡率趋势
Int J Cardiol Cardiovasc Risk Prev. 2025 Mar 7;25:200390. doi: 10.1016/j.ijcrp.2025.200390. eCollection 2025 Jun.
4
Investigation into Cardiac Myhc-α 334-352-Specific TCR Transgenic Mice Reveals a Role for Cytotoxic CD4 T Cells in the Development of Cardiac Autoimmunity.心肌肌球蛋白重链α334-352 特异性 TCR 转基因小鼠的研究揭示了细胞毒性 CD4 T 细胞在心脏自身免疫发展中的作用。
Cells. 2024 Jan 26;13(3):234. doi: 10.3390/cells13030234.
5
NF-κB-mediated anti-inflammatory effects of an organic light-emitting diode (OLED) device in lipopolysaccharide (LPS)-induced and inflammation models.有机发光二极管(OLED)装置通过 NF-κB 介导对脂多糖(LPS)诱导的 和 炎症模型的抗炎作用。
Front Immunol. 2022 Dec 6;13:1050908. doi: 10.3389/fimmu.2022.1050908. eCollection 2022.
6
Neurological Manifestations of Myocarditis.心肌炎的神经系统表现。
Curr Neurol Neurosci Rep. 2022 Jul;22(7):363-374. doi: 10.1007/s11910-022-01203-9. Epub 2022 May 19.
7
Suppression of NOD-like receptor protein 3 inflammasome activation and macrophage M1 polarization by hederagenin contributes to attenuation of sepsis-induced acute lung injury in rats.齐墩果酸通过抑制 NOD 样受体蛋白 3 炎性小体的激活和巨噬细胞 M1 极化,减轻内毒素血症诱导的大鼠急性肺损伤。
Bioengineered. 2022 Mar;13(3):7262-7276. doi: 10.1080/21655979.2022.2047406.
8
Combination of pseudoephedrine and emodin ameliorates LPS-induced acute lung injury by regulating macrophage M1/M2 polarization through the VIP/cAMP/PKA pathway.伪麻黄碱与大黄素联合通过VIP/cAMP/PKA途径调节巨噬细胞M1/M2极化改善脂多糖诱导的急性肺损伤。
Chin Med. 2022 Feb 5;17(1):19. doi: 10.1186/s13020-021-00562-8.
9
Efficacy of a Standardized Turmeric Extract Comprised of 70% Bisdemothoxy-Curcumin (REVERC3) Against LPS-Induced Inflammation in RAW264.7 Cells and Carrageenan-Induced Paw Edema.一种由70%双去甲氧基姜黄素组成的标准化姜黄提取物(REVERC3)对RAW264.7细胞中脂多糖诱导的炎症和角叉菜胶诱导的爪肿胀的疗效。
J Inflamm Res. 2021 Mar 12;14:859-868. doi: 10.2147/JIR.S291293. eCollection 2021.
10
Triggers of Inflammatory Heart Disease.炎症性心脏病的触发因素
Front Cell Dev Biol. 2020 Mar 24;8:192. doi: 10.3389/fcell.2020.00192. eCollection 2020.